In vitro reversal of hyperglycemia normalizes insulin action in fat cells from type 2 diabetes patients: Is cellular insulin resistance caused by glucotoxicity in vivo?
- 1 February 2003
- journal article
- Published by Elsevier BV in Metabolism
- Vol. 52 (2), 239-245
- https://doi.org/10.1053/meta.2003.50041
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Glutamine:fructose-6-phosphate amidotransferase activity in cultured human skeletal muscle cells: relationship to glucose disposal rate in control and non-insulin-dependent diabetes mellitus subjects and regulation by glucose and insulin.JCI Insight, 1996
- Glucosamine induces insulin resistance in vivo by affecting GLUT 4 translocation in skeletal muscle. Implications for glucose toxicity.JCI Insight, 1995
- Pathogenesis of NIDDM: A Balanced OverviewDiabetes Care, 1992
- Glucose ToxicityDiabetes Care, 1990
- Correction of hyperglycemia with phlorizin normalizes tissue sensitivity to insulin in diabetic rats.JCI Insight, 1987
- Adipocyte Insulin Binding and Action in Moderately Obese NIDDM Patients After Dietary Control of Plasma Glucose: Reversal of Postbinding AbnormalitiesDiabetes Care, 1987
- Improvement in in vitro insulin action after one month of insulin therapy in obese noninsulin-dependent diabetics. Measurements of glucose transport and metabolism, insulin binding, and lipolysis in isolated adipocytes.JCI Insight, 1983
- In vitro insulin resistance of human adipocytes isolated from subjects with noninsulin-dependent diabetes mellitus.JCI Insight, 1983
- Impact of obesity on metabolism in men and women. Importance of regional adipose tissue distribution.JCI Insight, 1983
- ADIPOSE-CELL SIZE AND IMMUNOREACTIVE INSULIN LEVELS IN OBESE AND NORMAL-WEIGHT ADULTSThe Lancet, 1972